MedDataX Logo

Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing

NCT ID: NCT02558478

Last Updated: 2016-12-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

39 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-09-30

Study Completion Date

2018-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Next Generation Sequencing (NGS) strategy is a powerful tool to identify genes implicated in very rare diseases for which the previous genetic explorations remain negative to date. The aim of this project is based on groups of patients with original clinical phenotypes including neurosensory impairment without genetic cause identified to date. The investigators will study these families using whole exome sequencing to potentially identify new genes and new underlying biological pathways involved in neurosensory diseases.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

NCT05589714

Inherited Retinal Degeneration Retinitis Pigmentosa
RECRUITING

Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGIN

NCT05499091

Rare Diseases Genetic Disease
RECRUITING NA

Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions

NCT02077894

Genetic Eye Disease
RECRUITING

Functional Genomics of Rare Genetic Diseases: Realization of Innovative Tools With High Diagnostic Power

NCT04152876

Rare Diseases
UNKNOWN

Interest of High-throughput Sequencing of RNAs for the Diagnosis of Heterogeneous Genetic Diseases

NCT03971292

DNA Sequencing Diagnosis of Genetic Diseases of Heterogeneous Origin
UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neurosensory Diseases Retinopathy Hearing Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

FAMILY_BASED

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

blood sampling

Intervention Type GENETIC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Original phenotype with neurosensory diseases
* Written, informed consent obtained

Exclusion Criteria

* Refusal to participate at the study
* Prior inclusion in a similar study (NGS)
Minimum Eligible Age

28 Days

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sophie SCHEIDECKER, MD

Role: PRINCIPAL_INVESTIGATOR

Hôpitaux Universitaires de Strasbourg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

LABORATOIRE DE CYTOGENETIQUE, Hôpitaux Universitaires de Strasbourg

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sophie SCHEIDECKER, MD

Role: CONTACT

[email protected]
33.3.88.12.73.33

Jean MULLER, PHD

Role: CONTACT

[email protected]
33.3.69.55.11.66

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sophie SCHEIDECKER, MD

Role: primary

[email protected]
33.3.88.12.73.33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5885

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exome Analysis in Hearing Impaired Patients
NCT03557879 UNKNOWN
Next Generation Sequencing Diagnostics - On the Road to Rapid Diagnostics for Rare Diseases
NCT02588638 UNKNOWN
Diagnostic Research in Patients With Rare Diseases - Solving the Unsolved Rare Diseases
NCT03491280 UNKNOWN
Genome Medical Sequencing for Gene Discovery
NCT01087320 RECRUITING
Genetic Analysis of Uncommon Disease Presentations in Non-US Populations
NCT06595940 RECRUITING
Study of New Mutations in Cone Disorders
NCT04658251 RECRUITING
Identification of Mutations Responsible for Rare Familial Skin Diseases by Next Generation Sequencing
NCT02509650 UNKNOWN
Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models
NCT05793515 COMPLETED
Identification of the Genetic Causes of Rare Diseases With Negative Exome Findings
NCT04315727 RECRUITING NA
A Natural History Study of the Gangliosidoses
NCT00668187 RECRUITING
Genetic Studies of Lysosomal Storage Disorders
NCT00001215 ENROLLING_BY_INVITATION
Whole Genome Trio Sequencing as a Standard Routine Test in Patients With Rare Diseases - "GENOME FIRST APPROACH"
NCT03954652 COMPLETED NA
Finding Genes for Rare Diseases
NCT02724995 WITHDRAWN
Transcriptomic Analysis of Fibroblasts and Blood in Patients With Rare Diseases
NCT07075107 NOT_YET_RECRUITING NA
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
NCT03548779 COMPLETED NA
Diagnostic Research in Patients With Rare Diseases -Solving the Unsolved Rare Diseases
NCT04024774 RECRUITING
Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes
NCT04731857 RECRUITING
Rare and Undiagnosed Disease Research Biorepository
NCT04703179 ENROLLING_BY_INVITATION
UW Undiagnosed Genetic Diseases Program
NCT04586075 RECRUITING
Research for Individualized Therapeutics in Rare Genetic Disease
NCT05236595 ENROLLING_BY_INVITATION
Exome and Genome Analysis to Elucidate Genetic Etiologies and Population Characteristics in the Plain Community
NCT02927158 RECRUITING
Neurogenetics Patient Registry
NCT02995538 RECRUITING
Longitudinal Study of Neurodegenerative Disorders
NCT03333200 RECRUITING
Genome Sequencing Strategies for Genetics Diagnosis of Patients With Intellectual Disability
NCT04154891 COMPLETED NA
Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder
NCT03829176 COMPLETED NA